\-\ Texto\\:\\ \ \(0\)\
\-\ tumor\\ was\\ initially\\ treated\\ on\\ daily\\ carboplatin\\ and\\ weekly\\ vincristine\\ with\\ craniospinal\\ irradiation\\.\\ subsequent\\ decrease\\ in\\ the\\ size\\ of\\ lesion\\ occurred\\ then\\ re\\-resection\\.\\ patient\\ then\\ received\\ stereotactic\\ radiotherapy\\.\\ ultimately\\,\\ patient\\ underwent\\ high\\-dose\\ chemotherapy\\ with\\ cytoxan\\ and\\ melphalan\\ with\\ autologous\\ stem\\ cell\\ rescue\\.\ \(0\)\
\-\ there\\ is\\ a\\ large\\ heterogeneous\\ mass\\ in\\ the\\ pineal\\ region\\ causing\\ severe\\ hydrocephalus\\ of\\ the\\ lateral\\ and\\ third\\ ventricles\\.\ \(0\)\
\-\ the\\ lobular\\ mass\\ is\\ iso\\ \\-\\ to\\ hypointense\\ on\\ t1\\-weighted\\ imaging\\ and\\ iso\\-\\ to\\ hypointense\\ on\\ t2\\ weighted\ \(0\)\
\-\ imaging\\ with\\ intense\\ enhancement\\ of\\ most\\ of\\ the\\ mass\\.\ \(1\)\
\-\ medulloepithelioma\ \(1\)\
\-\ pineoblastoma\ \(3\)\
\-\ non\\ germinomatous\\ germ\\ cell\\ tumor\ \(0\)\
\-\ pnet\ \(0\)\
\-\ presents\\ with\\ headache\\ and\\ vomiting\ \(0\)\
\-\ pt\\ is\\ alive\\ 2\\ years\\ from\\ time\\ of\\ presentation\\/resection\\.\\ \\ there\\ is\\ a\\ stable\\ cranial\\ nerve\\ iii\\ palsy\\ bilaterally\\ and\\ cognitive\\ difficulties\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ craniospinal\\:\\ 0\\.06781168018435768\ \(0\)\
\-\ melphalan\\:\\ 0\\.06781168018435768\ \(0\)\
\-\ germinomatous\\:\\ 0\\.06781168018435768\ \(0\)\
\-\ presentation\\/resection\\:\\ 0\\.06781168018435768\ \(0\)\
\-\ re\\-resection\\:\\ 0\\.06247977879543502\ \(0\)\
\-\ medulloepithelioma\\:\\ 0\\.06247977879543502\ \(0\)\
\-\ hypointense\\:\\ 0\\.06235914598721142\ \(0\)\
\-\ carboplatin\\:\\ 0\\.05936081642537222\ \(0\)\
\-\ cytoxan\\:\\ 0\\.05714787740651237\ \(0\)\
\-\ rescue\\:\\ 0\\.05543138855024922\ \(0\)\
\-\ alive\\:\\ 0\\.05543138855024922\ \(0\)\
\-\ high\\-dose\\:\\ 0\\.052843140576239886\ \(0\)\
\-\ iso\\:\\ 0\\.052843140576239886\ \(0\)\
\-\ pineoblastoma\\:\\ 0\\.05009948716132656\ \(0\)\
\-\ iso\\-\\:\\ 0\\.049366331932062524\ \(0\)\
\-\ autologous\\:\\ 0\\.048697013647526904\ \(0\)\
\-\ irradiation\\:\\ 0\\.04808130051157663\ \(0\)\
\-\ then\\:\\ 0\\.04678410582187831\ \(0\)\
\-\ weekly\\:\\ 0\\.046484074628667056\ \(0\)\
\-\ stereotactic\\:\\ 0\\.0447675857724039\ \(0\)\
\-\ vincristine\\:\\ 0\\.044392276817254425\ \(0\)\
\-\ cognitive\\:\\ 0\\.04369249390797961\ \(0\)\
\-\ difficulties\\:\\ 0\\.042459088907401306\ \(0\)\
\-\ pineal\\:\\ 0\\.0411521732397444\ \(0\)\
\-\ radiotherapy\\:\\ 0\\.04003538854863287\ \(0\)\
\-\ pnet\\:\\ 0\\.03983024818646241\ \(0\)\
\-\ stem\\:\\ 0\\.03906037542833177\ \(0\)\
\-\ ultimately\\:\\ 0\\.03836059251905695\ \(0\)\
\-\ lobular\\:\\ 0\\.03712718751847865\ \(0\)\
\-\ palsy\\:\\ 0\\.03644600753892907\ \(0\)\
\-\ t1\\-weighted\\:\\ 0\\.036064492607087745\ \(0\)\
\-\ cell\\:\\ 0\\.0355113955627921\ \(0\)\
\-\ occurred\\:\\ 0\\.03480814602167775\ \(0\)\
\-\ intense\\:\\ 0\\.03480814602167775\ \(0\)\
\-\ daily\\:\\ 0\\.034008225148415845\ \(0\)\
\-\ germ\\:\\ 0\\.034008225148415845\ \(0\)\
\-\ ventricles\\:\\ 0\\.030920983679767363\ \(0\)\
\-\ iii\\:\\ 0\\.030857672147948014\ \(0\)\
\-\ imaging\\:\\ 0\\.030801135760855428\ \(0\)\
\-\ tumor\\:\\ 0\\.030649727717089403\ \(0\)\
\-\ received\\:\\ 0\\.030548702596214672\ \(0\)\
\-\ decrease\\:\\ 0\\.030078797273292837\ \(0\)\
\-\ weighted\\:\\ 0\\.028581938431863844\ \(0\)\
\-\ cranial\\:\\ 0\\.028581938431863844\ \(0\)\
\-\ causing\\:\\ 0\\.028396572650486455\ \(0\)\
\-\ hydrocephalus\\:\\ 0\\.02826042205741414\ \(0\)\
\-\ mass\\:\\ 0\\.02742602323725149\ \(0\)\
\-\ non\\:\\ 0\\.02717165150175777\ \(0\)\
\-\ stable\\:\\ 0\\.027093950763400047\ \(0\)\
\-\ initially\\:\\ 0\\.026753694955886\ \(0\)\
\-\ third\\:\\ 0\\.026357282262692287\ \(0\)\
\-\ subsequent\\:\\ 0\\.025589082290844705\ \(0\)\
\-\ vomiting\\:\\ 0\\.02509660645419139\ \(0\)\
\-\ pt\\:\\ 0\\.024439721189482712\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.024170731975346197\ \(0\)\
\-\ nerve\\:\\ 0\\.02368420097297928\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.023561121424160503\ \(0\)\
\-\ headache\\:\\ 0\\.022576811058198448\ \(0\)\
\-\ underwent\\:\\ 0\\.022555354119063228\ \(0\)\
\-\ size\\:\\ 0\\.02203750670291363\ \(0\)\
\-\ bilaterally\\:\\ 0\\.02159004029633772\ \(0\)\
\-\ severe\\:\\ 0\\.020225460000507726\ \(0\)\
\-\ treated\\:\\ 0\\.019675775662183533\ \(0\)\
\-\ there\\:\\ 0\\.01956485471484598\ \(0\)\
\-\ years\\:\\ 0\\.01930187028475756\ \(0\)\
\-\ t2\\:\\ 0\\.018604528990387323\ \(0\)\
\-\ region\\:\\ 0\\.01856616328645625\ \(0\)\
\-\ time\\:\\ 0\\.01856616328645625\ \(0\)\
\-\ enhancement\\:\\ 0\\.017619144354792584\ \(0\)\
\-\ is\\:\\ 0\\.01730125471953002\ \(0\)\
\-\ on\\:\\ 0\\.016705177208432957\ \(0\)\
\-\ most\\:\\ 0\\.015175654936369817\ \(0\)\
\-\ large\\:\\ 0\\.014373403321777537\ \(0\)\
\-\ lateral\\:\\ 0\\.014205138812496541\ \(0\)\
\-\ 2\\:\\ 0\\.014154649973158049\ \(0\)\
\-\ \\-\\:\\ 0\\.014090218913141259\ \(0\)\
\-\ presents\\:\\ 0\\.013428033042368661\ \(0\)\
\-\ lesion\\:\\ 0\\.013388886353849652\ \(0\)\
\-\ patient\\:\\ 0\\.013178337398713661\ \(0\)\
\-\ from\\:\\ 0\\.009741813178109326\ \(0\)\
\-\ and\\:\\ 0\\.00830810795687162\ \(0\)\
\-\ was\\:\\ 0\\.00760213478625913\ \(0\)\
\-\ to\\:\\ 0\\.006570278591430558\ \(0\)\
\-\ in\\:\\ 0\\.0064830343098500765\ \(0\)\
\-\ a\\:\\ 0\\.006101535412593866\ \(0\)\
\-\ the\\:\\ 0\\.0053172801809086845\ \(0\)\
\-\ with\\:\\ 0\\.004500160618841913\ \(0\)\
\-\ of\\:\\ 0\\.004480915415307247\ \(0\)\
\-\ \\,\\:\\ 0\\.0020823851193637493\ \(0\)\
\-\ \\.\\:\\ 0\\.0019115134821647995\ \(0\)\
